<PAGE>
------------------------------
OMB APPROVAL
------------------------------
OMB Number
Expires:
Estimated average burden
hours per response ....... 0.5
------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 1)(1)
Altris Software, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
022091 10 2
- --------------------------------------------------------------------------------
(CUSIP Number)
Norman L. Smith
Solomon Ward Seidenwurm & Smith, LLP
401 B Street, Suite 1200
San Diego, CA 92101
(619) 231-0303
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
September 30, 1999
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the
following box [_].
Note: Schedules filed in paper format shall include a signed original and
five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of 4 Pages)
- ----------
(1) The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 022091 10 2 13D Page 2 of 4 Pages
________________________________________________________________________________
1 NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Spescom Limited
________________________________________________________________________________
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3 SEC USE ONLY
________________________________________________________________________________
4 SOURCE OF FUNDS*
WC
________________________________________________________________________________
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED
PURSUANT TO ITEMS 2(d) OR 2(e) [_]
________________________________________________________________________________
6 CITIZENSHIP OR PLACE OF ORGANIZATION
South Africa
________________________________________________________________________________
7 SOLE VOTING POWER
NUMBER OF 3,428,571
SHARES _________________________________________________________________
8 SHARED VOTING POWER
BENEFICIALLY
0
OWNED BY
_________________________________________________________________
EACH 9 SOLE DISPOSITIVE POWER
REPORTING 3,428,571
PERSON _________________________________________________________________
10 SHARED DISPOSITIVE POWER
WITH
0
________________________________________________________________________________
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,428,571
________________________________________________________________________________
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
22.3
________________________________________________________________________________
14 TYPE OF REPORTING PERSON*
CO
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
CUSIP No. 022091 10 2 13D Page 3 of 4 Pages
This Amendment No. 1 to Schedule 13D (this "Amendment No. 1") amends and
supplements the Schedule 13D filed by Spescom Limited ("Spescom") by furnishing
the information set forth below. Unless set forth below, all previous Items are
unchanged. Capitalized terms used herein which are not defined herein have the
meanings given to them in the Schedule 13D previously filed with the Securities
and Exchange Commission. Items 3 - 6 are hereby supplemented as follows:
________________________________________________________________________________
Item 3. Source and Amount of Funds or Other Consideration.
In September 1999, Spescom agreed to loan $500,000 to Altris (the "Loan").
The Loan will bear interest at 10% per annum with principal convertible at the
option of Spescom into common stock of the Company at $0.35 per share on or
before January 1, 2000. The source of the funds for the Loan was Spescom's
working capital.
________________________________________________________________________________
Item 4. Purpose of Transaction.
Under the terms of the Loan, the Loan is convertible at the option of
Spescom into Common Stock of Altris on or before January 1, 2000 at $0.35 per
share. Spescom is also considering purchasing additional shares of common stock
of Altris.
Although the foregoing reflects activities presently contemplated by
Spescom with respect to Altris, the foregoing is subject to change at any time,
and there can be no assurance that Spescom will take any of the actions set
forth above. Except as set forth above, Spescom has no plans or proposals with
respect to any of the matters set forth in paragraphs (a) through (j) of Item 4
of Schedule 13D.
________________________________________________________________________________
Item 5. Interest in Securities of the Issuer.
Spescom beneficially owns an aggregate of 3,428,571 shares of Common Stock,
or 22.3% of the issued and outstanding shares of Common Stock (after giving
effect to the possible conversion of the Loan).
Spescom has the sole power to vote or to direct the vote and the sole power
to dispose or to direct the disposition of all 3,428,571 shares of Common Stock
beneficially owned by it.
________________________________________________________________________________
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
Except as described herein, there were no other contracts, arrangements,
understandings or relationships with respect to securities of Altris. The terms
of the Loan are to be set forth in a written agreement to be executed by Altris
and Spescom in due course.
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
5 October 1999
-------------------------------------------
(Date)
/S/ HILTON ISAACMAN
-------------------------------------------
(Signature)
Hilton Isaacman, Director Corporate Finance
-------------------------------------------
(Name/Title)
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).
